Regenerex, LLC, Louisville, KY, USA.
Transplantation. 2011 Apr 27;91(8):908-15. doi: 10.1097/TP.0b013e31820fafb4.
FoxP3/CD4/CD25 regulatory T cells (Treg) play an important role in maintaining peripheral tolerance and are potent suppressors of T-cell activation. In this study, we evaluated the role of Treg in peripheral tolerance to composite tissue allografts (CTA).
Mixed allogeneic chimeric rats were prepared by preconditioning recipients with anti-αβ-T-cell receptor monoclonal antibody followed by total body irradiation. Animals received T-cell-depleted August Copenhagen Irish bone marrow cells followed by antilymphocyte serum and FK-506. A modified osteomyocutaneous hindlimb flap composed of bone and all limb tissue components was placed in animals with chimerism greater than or equal to 1% on day 28. Recipients with CTA surviving more than or equal to 6 months were evaluated for Treg. Skin samples from tolerant long-term allogeneic transplanted, syngeneic transplanted, rejected, and naïve animals were immunostained with fluorochrome-conjugated anti-FoxP3 and anti-CD4 monoclonal antibody and visualized under a laser confocal microscope.
Significant CD4/FoxP3 Treg infiltrates were observed in tolerant donor-allograft skin samples. No graft infiltrating FoxP3 cells were observed in rejector, naïve, or skin from syngeneic CTA. In parallel experiments, mixed leukocyte reaction assays were performed to investigate the suppressor function of Treg cells. Splenocytes from tolerant, rejected, and naïve rats were sorted by flow cytometry for CD4/CD25 T cells. Treg demonstrated similar suppressive levels between the three groups.
These data suggest that Treg may play an important role in maintenance of tolerance and promoting graft acceptance in long-term CTA acceptors and may explain the favorable outcomes observed in clinical CTA recipients.
FoxP3/CD4/CD25 调节性 T 细胞(Treg)在维持外周耐受方面发挥着重要作用,是 T 细胞活化的有效抑制剂。在本研究中,我们评估了 Treg 在复合组织同种异体移植物(CTA)外周耐受中的作用。
通过用抗-αβ-T 细胞受体单克隆抗体预处理受体,然后进行全身照射,制备混合同种异体嵌合大鼠。动物接受 T 细胞耗竭的奥古斯塔斯·科彭丹麦爱尔兰骨髓细胞,然后接受抗淋巴细胞血清和 FK-506。在嵌合率大于或等于 1%的第 28 天,将包含骨和所有肢体组织成分的改良骨肌皮瓣置于动物体内。对 CTA 存活时间大于或等于 6 个月的受者进行 Treg 评估。用荧光素标记的抗 FoxP3 和抗 CD4 单克隆抗体对耐受长期同种异体移植、同基因移植、排斥和未致敏动物的皮肤样本进行免疫染色,并在激光共聚焦显微镜下观察。
在耐受的供体-移植物皮肤样本中观察到显著的 CD4/FoxP3 Treg 浸润。在排斥者、未致敏者或同基因 CTA 的皮肤中未观察到移植物浸润的 FoxP3 细胞。在平行实验中,进行混合白细胞反应测定以研究 Treg 细胞的抑制功能。通过流式细胞术对来自耐受、排斥和未致敏大鼠的脾细胞进行 CD4/CD25 T 细胞分选。Treg 在三组之间表现出相似的抑制水平。
这些数据表明,Treg 可能在长期 CTA 接受者中维持耐受和促进移植物接受方面发挥重要作用,并解释了临床 CTA 接受者中观察到的良好结果。